INGESTEM, the national infrastructure in biology and health certified by the “Investissements d’Avenir” program (2012-2019 [1]), is the first French network of therapeutic innovations based on induced pluripotent stem cells (iPS) cells and human tissue engineering. Our ambition is to use the major potential of cellular reprogramming techniques to generate models of human diseases and regenerative medicine.